You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Decitabine combined with HAAG

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

PFS Trial (Decitabine Injection, tirelizumab)

Not yet recruiting
  • PFS
  • (no location specified)
Nov 24, 2022

Induction Chemo, Acute T-Lymphocytic Leukemia, T-cell Lymphoblastic Lymphoma Leukemia Trial in Suzhou (Decitabine combined with

Recruiting
  • Induction Chemotherapy
  • +3 more
  • Decitabine combined with HAAG Regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 22, 2020

Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
  • Venetoclax-Decitabine/Azacitidine Association
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

AML/MDS Trial in Worldwide (Decitabine, Midostaurin)

Active, not recruiting
  • AML/MDS
  • Antwerpen, Belgium
  • +36 more
Dec 29, 2021

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
  • Defactinib
  • Sydney, New South Wales, Australia
  • +3 more
Jan 12, 2023

Hodgkin Lymphoma, Adult, Relapse, Refractory Hodgkin Lymphoma Trial in Tianjin (PD-1 inhibitor)

Recruiting
  • Hodgkin Lymphoma, Adult
  • +2 more
  • PD-1 inhibitor
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 14, 2021

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Bisantrene Dihydrochloride (high dose)
  • +3 more
  • Newcastle, New South Wales, Australia
    Calvary Mater
Jul 14, 2022

Acute Myeloid Leukemia, Relapsed, Adult Trial in Suzhou (CDIAG regimen)

Completed
  • Acute Myeloid Leukemia, Relapsed, Adult
  • CDIAG regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Mar 16, 2022

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
Sep 23, 2021

Pancreatic Ductal Adenocarcinoma, Sarcoma Trial in Iowa City (Decitabine, Gemcitabine)

Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Dec 3, 2021

Malignancy Trial in Shenzhen (Decitabine combined with NK cell infusion)

Recruiting
  • Malignancy
  • Decitabine combined with NK cell infusion
  • Shenzhen, Guangdong, China
    Shenzhen University General hospital
Nov 22, 2021

Acute Myeloid Leukemia, Adult Trial in Suzhou (venetoclax combined with decitabine)

Unknown status
  • Acute Myeloid Leukemia, Adult
  • venetoclax combined with decitabine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 8, 2021

Acute Myeloid Leukemia, Induction Chemo Trial in Suzhou (Decitabine plus HAAG regimen, Idarubicine plus Cytarabine regimen)

Unknown status
  • Acute Myeloid Leukemia
  • Induction Chemotherapy
  • Decitabine plus HAAG regimen
  • Idarubicine plus Cytarabine regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 10, 2019

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib plus R-ICE, Decitabine plus R-ICE, Chidamide plus R-ICE)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus R-ICE
  • +4 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Apr 26, 2022

Acute Myeloid Leukemia, Induction Chemo Trial in Suzhou (Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF)

Unknown status
  • Acute Myeloid Leukemia
  • Induction Chemotherapy
  • Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Sep 8, 2019

Patients With Digestive System Tumors Resistant to PD-1 Inhibitors Trial (decitabine+ TQB2450 injection, decitabine+ TQB2450

Unknown status
  • Patients With Digestive System Tumors Resistant to PD-1 Inhibitors
  • decitabine＋ TQB2450 injection
  • decitabine＋ TQB2450 injection＋Anlotinib
  • (no location specified)
Oct 28, 2020

Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Edegem, Antwerpen, Belgium
  • +52 more
Sep 13, 2022

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Acute Myeloid Leukemia Trial (Camrelizumab(SHR-1210), Decitabine)

Unknown status
  • Acute Myeloid Leukemia
  • (no location specified)
Apr 16, 2020

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022